News Headlines Article

FDA’s Social Media Gambit ‘A Long Shot,’ Says Patient Advocate
Health Leaders Media

After more than a decade of ambivalence toward social media, the U.S. Food and Drug Administration is wading into the deeper waters of online communication platforms. In June, the FDA distributed a draft of long-awaited guidelines for industry when using social media.

Now the agency wants to employ listening technologies to improve the FDA Adverse Events Reporting System.

In late February, the agency quietly announced that it was looking for a contractor to take on the task of listening for adverse drug effects. It wanted to partner with an organization able to monitor social media sites, including Facebook, Twitter, LinkedIn, YouTube, Wikipedia for mentions of key words that would indicate negative side effects or other problems.